Bimekizumab National Webinar series; ÂPsoriasis Redefined: The next innovation in skin has arrivedÂ: Webinar 1 - The Bimekizumab Difference
14 Oct 2021
About the event
The National Webinar series will consist of three hybrid meetings; each comprising live-streamed presentations and interactive Q&A sessions with the audience. Our overall objective is to provide delegates with the clinical knowledge and confidence to use bimekizumab appropriately as a new biologic therapy in suitable patients with plaque psoriasis.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.